Graduate School of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan;
Department of Bioengineering, Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University Graduate School, Tokushima, Japan.
Anticancer Res. 2022 Aug;42(8):4017-4023. doi: 10.21873/anticanres.15898.
BACKGROUND/AIM: Boron tracedrugs possess global molecular tracking abilities and localized destructive power. We investigated the molecular properties of synthesized boron tracedrugs, including UTX-51, and their interactions with the advanced glycation end-product (AGE)-related protein bovine serum albumin (BSA).
A conformational analysis of the compounds used in the present study was performed using CAChe (Fujitsu Inc., Tokyo, Japan) and the degree of stereo-hydrophobicity of the conformers obtained was verified using Mopac (Fujitsu Inc.). The interactive properties of global minimum conformers of the derivatives tested with BSA were assessed using Molegro Virtual Docker (CLC bio., Aarhus, Denmark).
Among the compounds investigated, UTX-51 was confirmed to interact with BSA based on the formation of hydrogen bonds between BSA and UTX-51.
UTX-51 is a promising boron tracedrug and can be used as the lead structure for developing a therapeutic agent for AGE-related diseases, including cancer.
背景/目的:硼示踪剂具有全局分子跟踪能力和局部破坏能力。我们研究了合成的硼示踪剂,包括 UTX-51 的分子特性,以及它们与晚期糖基化终产物(AGE)相关蛋白牛血清白蛋白(BSA)的相互作用。
使用 CAChe(富士通公司,东京,日本)对本研究中使用的化合物进行构象分析,并使用 Mopac(富士通公司)验证获得的构象的立体疏水性程度。使用 Molegro Virtual Docker(CLC bio.,奥胡斯,丹麦)评估测试衍生物的全局最小构象与 BSA 的相互作用特性。
在所研究的化合物中,UTX-51 被证实与 BSA 相互作用,这是基于 BSA 和 UTX-51 之间形成氢键。
UTX-51 是一种有前途的硼示踪剂,可作为开发用于治疗 AGE 相关疾病(包括癌症)的治疗剂的先导结构。